Get the Stockscreener App
0.50
10.13%
0.046
After Hours:
.48
-0.02
-4.00%
Nanovibronix Inc stock is traded at $0.50, with a volume of 2.03M.
It is up +10.13% in the last 24 hours and down -28.57% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
See More
Previous Close:
$0.454
Open:
$0.454
24h Volume:
2.03M
Relative Volume:
0.66
Market Cap:
$3.07M
Revenue:
$3.29M
Net Income/Loss:
$-3.09M
P/E Ratio:
-0.4065
EPS:
-1.23
Net Cash Flow:
$-2.46M
1W Performance:
-15.25%
1M Performance:
-28.57%
6M Performance:
-14.82%
1Y Performance:
-46.81%
1-Day Range:
$0.454
$0.60
1-Week Range:
$0.4225
$0.60
52-Week Range:
$0.365
$1.52
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare NAOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.50 | 3.07M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Nanovibronix Inc Stock (NAOV) Latest News
NAOV’s 2023 Market Dance: Down -23.05% – Time to Invest? - The InvestChronicle
In the Green: MKDWELL Tech Inc (MKDW) Closes at 0.37, Up/Down -20.43 from Previous Day - The Dwinnex
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Daily Market Movement: NanoVibronix Inc (NAOV) Sees a -5.63 Decrease, Closing at 0.45 - The Dwinnex
Closing Bell Recap: FMC Corp (FMC) Ends at 35.92, Reflecting a -33.53 Downturn - The Dwinnex
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Whirlpool Corp (WHR) Shares Rise Despite Market Challenges - The News Heater
BBB Foods Inc (TBBB) Stock Price and Analyst Predictions - The News Heater
NAOV’s price-to-free cash flow ratio: A closer look at its relevance - US Post News
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NanoVibronix Secures $12M Minimum Purchase Commitment for PainShield - MPO-mag
NanoVibronix stock touches 52-week low at $0.44 amid market challenges - MSN
NanoVibronix stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix’s UroShield trial results hold potential to advance urinary care: GlobalData - Express Healthcare
NanoVibronix stock touches 52-week low at $0.46 amid market challenges - Investing.com Canada
NanoVibronix stock touches 52-week low at $0.46 amid market challenges By Investing.com - Investing.com South Africa
Controladora Vuela Compañía de Aviación (NYSE:VLRS) Stock Price Expected to Rise, UBS Group Analyst Says - Defense World
NanoVibronix (NASDAQ:NAOV) Enters into Securities Exchange AgreementOn January 7, 2025, NanoVibronix, Inc. filed an 8-K form with the Securities and Exchange Commission, disclosing its recent agreement with an institutional investor. The company en - Defense World
NanoVibronix advances medical device development By Investing.com - Investing.com Canada
NanoVibronix announces exchange agreement with investor By Investing.com - Investing.com
NanoVibronix advances medical device development - Investing.com
NanoVibronix Unveils Next-Gen PainShield and UroShield with Enhanced Therapy Features - StockTitan
Transforming catheter care: NanoVibronix completes successful UroShield US trial - Yahoo Finance
NanoVibronix Announces Completion of Pilot Phase of UroShield® Clinical Study at University of MichiganOn January 6, 2025, NanoVibronix Inc. (NASDAQ: NAOV) revealed the successful conclusion of the initial phase of a Randomized Control Trial study at - Defense World
NanoVibronix Advances UroShield® Trial and Receives Nasdaq Extension - TipRanks
NanoVibronix completes pilot study of UroShield - Mass Device
NanoVibronix “achieves goals” of US trial pilot phase with UroShield - Yahoo Finance
NanoVibronix, Inc. Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan - Marketscreener.com
NanoVibronix's UroShield Completes Key Clinical Trial Phase at University of Michigan - StockTitan
NanoVibronix (NASDAQ: NAOV) Shares Key Insights from Annual Stockholder Meeting - Defense World
NanoVibronix Presents at Annual Stockholders Meeting - TipRanks
NanoVibronix Renews Distribution Agreement with Ultra Pain Products Inc., Secures $12 Million Minimum Purchase Commitment - Defense World
NanoVibronix renews distribution with UPPI through 2029 By Investing.com - Investing.com Nigeria
NanoVibronix renews distribution agreement with Ultra Pain Products - MSN
NanoVibronix renews distribution with UPPI through 2029 - Investing.com India
NanoVibronix, Inc. Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement - Marketscreener.com
NanoVibronix Secures $12M Distribution Deal for PainShield in Major Non-Opioid Pain Management Partnership - StockTitan
NanoVibronix (STU:56R0) Volatility : 85.95% (As of Dec. 04, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Price-to-Operating-Cash-Flow : (As of Dec. 04, 2024) - GuruFocus.com
NanoVibronix Faces Potential Delisting from Nasdaq Due to Non-Compliance - Defense World
NanoVibronix faces potential Nasdaq delisting - Investing.com
NanoVibronix faces potential Nasdaq delisting By Investing.com - Investing.com Nigeria
NanoVibronix Third Quarter 2024 Earnings: US$0.36 loss per share (vs US$0.42 loss in 3Q 2023) - Yahoo Finance
Armistice Capital, LLC Expands Stake in NanoVibronix Inc - GuruFocus.com
NanoVibronix Inc (NAOV) Quarterly 10-Q Report - Quartzy
NanoVibronix expands global reach, eyes new markets By Investing.com - Investing.com South Africa
NanoVibronix expands global reach, eyes new markets - Investing.com
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):